| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |